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ABSTRACT: Post-translational covalent modiﬁcation by ubiquitin and ubiquitin-like proteins (UBLs) is a
major eukaryotic mechanism for regulating protein function. In general, each UBL has its own E1 that
serves as the entry point for a cascade. The E1 ﬁrst binds the UBL and catalyzes adenylation of the
UBL’s C-terminus, prior to promoting UBL transfer to a downstream E2. Ubiquitin’s Arg 72, which
corresponds to Ala72 in the UBL NEDD8, is a key E1 selectivity determinant: swapping ubiquitin and
NEDD8 residue 72 identity was shown previously to swap their E1 speciﬁcity. Correspondingly, Arg190
in the UBA3 subunit of NEDD8’s heterodimeric E1 (the APPBP1-UBA3 complex), which corresponds
to a Gln in ubiquitin’s E1 UBA1, is a key UBL selectivity determinant. Here, we dissect this speciﬁcity
with biochemical and X-ray crystallographic analysis of APPBP1-UBA3-NEDD8 complexes in which
NEDD8’s residue 72 and UBA3’s residue 190 are substituted with different combinations of Ala, Arg, or
Gln. APPBP1-UBA3’s preference for NEDD8’s Ala72 appears to be indirect, due to proper positioning
of UBA3’s Arg190. By contrast, our data are consistent with direct positive interactions between ubiquitin’s
Arg72 and an E1’s Gln. However, APPBP1-UBA3’s failure to interact with a UBL having Arg72 is not
due to a lack of this favorable interaction, but rather arises from UBA3’s Arg190 acting as a negative
gate. Thus, parallel residues from different UBL pathways can utilize distinct mechanisms to dictate
interaction selectivity, and speciﬁcity can be ampliﬁed by barriers that prevent binding to components of
different conjugation cascades.
Post-translational modiﬁcation by ubiquitin and ubiquitin-
like proteins (UBLs) is a predominant eukaryotic regulatory
mechanism with roles in cell division, the immune response,
development, and many other processes (1). A widely
recognized functional consequence of a UBL modiﬁcation
is ubiquitin-mediated proteolysis, although ubiquitin can be
attached to targets via a variety of linkages that signal
different effects on targets (2). In addition to ubiquitin, there
are over 10 UBLs in higher eukaryotes that when conjugated
to macromolecules, alter the function of their important
targets (3). These include ubiquitin’s closest relative NEDD8,
which has its own functions despite 58% sequence identity
with ubiquitin. The NEDD8 pathway is essential for the
regulation of the cell cycle and plays roles in signaling
pathways and embryogenesis (4–7). Among NEDD8’s targets
are cullin subunits of cullin-RING ligases, and several
ribosomal subunits (8–14).
Prior to conjugation, ubiquitin and NEDD8 precursors are
processed by deubiquitinating enzymes (DUBs). Then,
ubiquitin and NEDD8 are covalently attached to targets by
parallel but distinct hierarchical cascades of enzymes in
classes known as E1, E2 and E3 (15–18). First, E1 initiates
a cascade by catalyzing C-terminal adenylation of the UBL,
and subsequently forming a covalent thioester-linked inter-
mediate between its catalytic cysteine and the UBL’s C
terminus. E1 further catalyzes a transthiolation reaction,
whereby the UBL is transferred from the E1’s catalytic
cysteine to the E2’s catalytic cysteine. Often, an E3 facilitates
UBL transfer from an E2 to a target. The cycle can be reset
by UBL removal from targets by DUBs.
Despite the close similarity between ubiquitin and NEDD8
sequences, these UBLs have their own conjugation cascades,
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ultimately understand the unique functions of different UBLs,
it is important to understand the molecular “code” by which
UBLs are distinguished by their enzymatic and effector
machineries. To date, some of the best progress in this area
has been in deciphering sequences dictating E1 discrimina-
tion between ubiquitin and NEDD8. Several previous studies
indicate that E1s provide critical UBL selection during initial
noncovalent binding, and that this selection hinges on the
identity of a UBL’s residue 72, the only C-terminal tail
residue differing between ubiquitin (Arg) and NEDD8 (Ala)
(Figure 1A). First, ubiquitin’s Arg 72 was identiﬁed as a
critical determinant for E1 binding during adenylation (19).
Second, “ubiquitinizing” NEDD8 with an Ala72Arg mutation
allows binding to ubiquitin’s E1 (20), and “NEDD8ylizing”
ubiquitin with Arg72Leu or Arg72Ala mutations allows
ubiquitin to be activated by NEDD8’s E1 (21, 22). Third, a
“NEDD8ylized” ubiquitin can be transferred to NEDD8’s
E2, albeit with ∼80-fold diminished kcat/Km, suggesting either
that the same UBL residue dictates both E1 and E2
selectivity, or E1 is fully responsible for dictating an E2’s
UBL selection (22). This latter notion was supported by the
ﬁnding that an E2’s UBL selectivity is dictated by side-chains
involved in E1-, but not UBL- binding (23). Interestingly,
ubiquitin and NEDD8’s residue 72 also plays a fundamental
role in DUB speciﬁcity (24–26).
The basis for UBL selectivity has been partially character-
ized for NEDD8’s E1. The crystal structure of NEDD8’s
heterodimeric E1 (APPBP1-UBA3) in complex with NEDD8
and ATP allowed modeling ubiquitin in place of NEDD8 in
the structure (21). In the model, a conserved Arg in UBA3
(Arg190) would clash with ubiquitin’s speciﬁcity-conferring
Arg72. By contrast, the corresponding residue in E1s for
ubiquitin is absolutely conserved throughout evolution as a
glutamine (Figure 1B), and a UBA3 Arg190Gln substitution
allows adenylation of ubiquitin to some extent (21). Interest-
ingly, in the wild-type E1-UBL complex, although UBA3’s
Arg190 faces NEDD8’s Ala72, these two residues do not
contact each other. There are two simplistic explanations for
how the UBA3 Arg190Gln mutation allows NEDD8’s E1
to catalyze ubiquitin adenylation. First, it is possible that the
polar Gln attracts ubiquitin through positive interactions with
Arg72, and because NEDD8’s E1 lacks this Gln it fails to
bind ubiquitin. Second, it is possible that NEDD8’s E1
actively prevents ubiquitin binding via electrostatic repulsion,
with UBA3’s Arg190 repelling ubiquitin’s Arg72. Here we
structurally and biochemically dissect roles of NEDD8’s
residue 72 and UBA3’s residue 190, in order to gain further
insights into mechanisms underlying E1-UBL selectivity.
EXPERIMENTAL PROCEDURES
Protein Preparation. Mutations were generated by PCR,
and the entire coding sequence for each construct was veriﬁed
by sequencing. Expression and puriﬁcation of human AP-
PBP1-UBA3, Ubc12, NEDD8, ubiquitin, and variants have
been described (21, 23, 27, 28). Biochemical experiments
were performed with full-length versions of APPBP1-UBA3.
Surface plasmon resonance experiments examining nonco-
valent UBL interaction with APPBP1-UBA3 utilize UBA3
mutants harboring the catalytic Cys216Ala mutation, whereas
those examining transthiolation retain the catalytic Cys. For
BIACORE experiments, GST-APPBP1-UBA3 (Cys216Ala)
and mutants were puriﬁed by glutathione afﬁnity and gel
ﬁltration chromatography in 50 mM Tris-HCl, 150 mM
NaCl, 0.5 mM DTT, pH 7.6. NEDD8 and variants were
expressed as His-MBP-fusions from pRSF-1b with a GGS
linker inserted upstream of NEDD8 to facilitate thrombin
cleavage. His-MBP-NEDD8 was puriﬁed by nickel afﬁnity,
treated with thrombin, and dialyzed at 4 °C in 50 mM Tris-
HCl and 150 mM NaCl, pH 7.6. NEDD8 was puriﬁed further
by gel ﬁltration and concentrated to 300 µM. His-ubiquitin
was expressed in BL21 (DE3) RIL from pET15b, puriﬁed
by nickel afﬁnity chromatography and concentrated to 550
µM. Crystallographic experiments utilized truncated AP-
PBP1-UBA3 lacking APPBP1 residues 254-258 and UBA3
residues 1-12 to facilitate crystallization as described
previously (21). APPBP1-UBA3-NEDD8 mutant complexes
for crystallography were expressed and puriﬁed as for the
wild-type complex (21), except that NEDD8 and variants
were expressed from pGEX-2TK (27) and thus retain
additional vector sequences upstream of NEDD8, which we
ﬁnd improve crystal contacts. Proteins/complexes were
aliquotted, ﬂash-frozen in liquid nitrogen, and stored at -80
°C until use.
Surface Plasmon Resonance. Kinetic studies were per-
formed at 25 °C using a BIACORE 3000 (Biacore, Inc.)
surface plasmon resonance (SPR) instrument. Anti-GST
FIGURE 1: Sequence conservation at a UBL’s residue 72 and E1
residues corresponding to UBA3’s 190. (A) Sequence alignment
of the C-terminal tail region of NEDD8 and ubiquitin (UBIQ) from
the following organisms: Hs, human; Mm, M. musculus; AT, A.
thaliana; Ce, C. elegans; Dm, D. melanogaster. NEDD8 and
ubiquitin residue 72 are highlighted. (B) Sequence alignment of
the E1 region containing Arg190 (highlighted) from the UBA3
subunit of NEDD8’s E1 (E1 NEDD8) and the corresponding Gln
from the UBA1 ubiquitin E1 (E1 UBIQ). (C) Nomenclature and
sequences for NEDD8, ubiquitin, and E1 NEDD8 (APPBP1-UBA3)
mutants.
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carboxymethyl dextran-coated gold surface (CM-4 Chip;
Biacore, Inc.). The carboxymethyl groups of dextran were
activated with N-ethyl-N′-(3-dimethylaminopropyl) carbo-
diimide (EDC) and N-hydroxysuccinimide (NHS), and anti-
GST antibodies were attached at pH 5.0 in 10 mM sodium
acetate. Any remaining reactive sites were blocked by
reaction with ethanolamine. Anti-GST antibodies were
immobilized at levels of ∼4000 RU for each ﬂow cell.
The kinetics of association and dissociation were monitored
at a ﬂow rate of 100 µL/min. GST-APPBP1-UBA3 constructs
were captured to a level of ∼1250-1450 RU for each
experiment. GST was captured on the reference surface to
account for any nonspeciﬁc binding to the GST tag. The UBL
analytes were prepared in 10 mM Tris (pH 7.6), 150 mM NaCl,
0.1 mg/mL bovine serum albumin, and 0.005% P20 surfactant.
Binding was measured for concentration ranges of 41 nM to
10 µM for all UBLs. To account for injection artifacts, a series
of sensorgrams was recorded throughout the experiment after
injecting only buffer (blank injections). The analytes dissociated
completely from the chip surfaces, eliminating the need for a
regeneration step. Data reported are the difference in SPR signal
between the ﬂow cell containing the APPBP1-UBA3 construct
and the reference cell without APPBP1-UBA3. Additional
instrumental contributions to the signal were removed by
subtraction of the average signal of the blank injections from
the reference-subtracted signal (29). Triplicate injections were
made, and the data were analyzed globally by equilibrium
afﬁnity analysis using the software package Scrubber 2 (Bio-
logic Software).
Ubc12-UBL Thioester Assays. APPBP1-UBA3-catalyzed
formation of the thioester-linked Ubc12-NEDD8 covalent
intermediate was assayed in 20 µL volumes containing 100
nM of APPBP1-UBA3 or mutants, 3 µM Ubc12, 4 µM wild-
type NEDD8 or mutants, and 50 mM Tris-HCl, 50 mM
NaCl, 10 mM MgCl2, 5 mM ATP, 1 mM DTT, pH 7.6. The
reactions were started by adding the E1 enzyme to the assay
mixture, incubated at room temperature for 5 min, and
quenched by the addition of 10 µL2 × nonreducing
SDS-PAGE sample buffer. Reaction products were resolved
by 15% SDS-polyacrylamide gels, and transferred to
nitrocellulose membranes. The membranes were saturated
with 3% bovine serum albumin (BSA) in TBS-T (50 mM
Tris-HCl, 150 mM NaCl, 0.1% Tween 20, pH 7.4) prior to
incubation with anti-NEDD8 antibody. Anti-NEDD8 poly-
clonal antibodies (RCA) were raised in rabbits against the
peptide corresponding to residues 12-26 of the human
NEDD8 protein, and afﬁnity puriﬁed as described (30). After
extensive washing, detection of bound antibodies was carried
out using horseradish peroxidase-labeled secondary antibody
and enhanced chemiluminescence (Amersham). Experiments
comparing reactivity across UBLs were performed similarly,
except with His-NEDD8 and His-ubiquitin, allowing com-
parable detection with anti-His antibodies (Qiagen).
Crystallization, Data Collection, and Structure Determi-
nation. All crystals were grown at 18 °C using the hanging-
drop vapor diffusion method after mixing 1 µL complexes
with an equal volume of the corresponding reservoir solution.
Crystals of APPBP1 (∆254-258)-UBA3(∆N12 C216A)
Arg190Gln-NEDD8Ala72Arg (hereafter referred to as AP-
PBP1-UBA3 Arg190Gln-NEDD8Ala72Arg or “ubiquiti-
nized”, Figure 1C) were grown with reservoir solution
containing 0.1 M Tris, 0.2 M NaCl, 10% PEG 10K, 8%
PEG400, 5 mM DTT, pH 8.0, and were soaked for 5 min in
50 mM Tris, 0.2 M NaCl, 14% PEG 10K, 8% PEG400, 5
mM DTT, pH 8.0 supplemented with 10% glycerol, and then
for 5 min in the same solution supplemented with 20%
glycerol, prior to freezing in a solution containing 30%
glycerol. Data for these crystals were collected at the X25
beamline at the National Synchrotron Light Source. Crystals
of APPBP1(∆254-258)-UBA3(∆N12 C216A)Arg190Ala-
NEDD8Ala72Arg (hereafter referred to as APPBP1-
UBA3Arg190Ala-NEDD8Ala72-Arg or “wild-type-oppo-
site”, Figure 1C) and APPBP1(∆254-258)-UBA3(∆N12
C216A)-NEDD8Ala72Gln (hereafter referred to as APPBP1-
UBA3Arg190 (wt)-NEDD8Ala72Gln or “ubiquitinized-op-
posite”, Figure 1C) were grown with reservoir solution
containing 0.1 M Tris, 0.4 M ammonium acetate, 9-10%
PEG 10K, 5 mM DTT, pH 7.0-8.0. These crystals were
soaked in 0.1 M Tris, 0.4 M ammonium acetate, 12-13%
PEG 10K, 5 mM DTT, pH 7.0-8.0 supplemented with
increasing concentrations of glycerol (5-30%, in 5% incre-
ments) prior to ﬂash-freezing in the presence of 30% glycerol
and data collection at the 8.2.2 beamline at the Advanced
Light Source. All crystals formed with four complexes in
the asymmetric unit in the space group P212121, with unit
cells and packing similar to the wild-type complex reported
previously (21). Reﬂection data were indexed, integrated and
scaled using HKL2000 (31). The structure of APPBP1-
UBA3Arg190Ala-NEDD8Ala72Arg was determined ﬁrst, by
rigid body reﬁnement using a model derived from the
structure of wild-type APPBP1-UBA3-NEDD8 (21), in
which UBA3’s Arg190 side-chain was truncated after the
 -carbon. Rigid body reﬁnement, simulated annealing, energy
minimization and restrained B-factor reﬁnement were carried
out using the program CNS (32), iteratively with manual
rebuilding using O (33). The structure of APPBP1-
UBA3Arg190Ala-NEDD8Ala72Arg, but with NEDD8’s
residue 72 side-chain truncated after the  -carbon, was then
used as a model for the other two structures, which were
reﬁned using a similar protocol. Simulated annealing (2000
K) omit maps conﬁrm the presence and the correct placement
of mutated residues in all three structures. In one complex
from the asymmetric unit of all these structures, additional
vector-derived residues N-terminal of NEDD8 participate in
crystal packing. The four complexes in the asymmetric unit
for the ﬁnal model of APPBP1-UBA3Arg190Ala-
NEDD8Ala72Arg contain: APPBP1 residues 6-204, 207-
534; 6-200, 202, 204-205, 208-534; 6-203, 208-253,
261-534; 6-203, 205-534; UBA3 residues -1 and 12-442;
-1 and 12-442; -1 and 12-441; -1 and 12-441; and
NEDD8 residues -10 to -1 and 1-76; 1-76; 1-76; 1-76,
respectively. The four complexes in the asymmetric unit for
the ﬁnal model of APPBP1-UBA3Arg190Gln-
NEDD8Ala72Argcontain:APPBP1residues6-200,208-534;
6-201, 211-534; 6-199, 212-252, 262-534; 6-200,
209-534; UBA3 residues -1 and 12-442; -1 and 12-441;
-1 and 12-441; -1 and 12-441; and NEDD8 residues -10
to -1 and 1-76; 1-76; -2t o-1 and 1-76; -1 and 1-76,
respectively. The four complexes in the asymmetric unit for
the ﬁnal model of APPBP1-UBA3Arg190 (wt)-
NEDD8Ala72Glncontain:APPBP1residues6-204,207-534;
6-203,205-534;6-200,202,204-205,208-253,260-534;
6-203, 208-534; UBA3 residues -1 and 12-442; -1 and
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residues -10 to -1 and 1-76; 1-76; 1-76; 1-76,
respectively. Other residues are not modeled, presumably due
to disorder. Ramachandran statistics were analyzed with
Procheck (34). Structures are shown using Pymol (35).
RESULTS
UBA3’s Arg190 Gates against Binding to a UBL with a
Basic Side-Chain at Residue 72. In order to quantify effects
of mutations on APPBP1-UBA3-NEDD8 interactions, we
developed a binding assay using BIACORE (Table 1, Figure
2). In our assay, GST-APPBP1-UBA3 binds NEDD8 with a
Kd value of 333 ( 1 nM. Furthermore, a NEDD8 mutant
harboring the “ubiquitinizing” Ala72Arg mutant does not
display any binding in our assay. Thus, we examined the role
of UBA3’s Arg190 in this discrimination. Consistent with
previous studies, “ubiquitinizing” GST-APPBP1-UBA3 with
an Arg190Gln mutation allows binding to NEDD8Ala72Arg,
with a Kd of 1.02 ( 0.1 µM.
We next asked whether relief from negative repulsion from
the E1’s Arg is sufﬁcient to allow binding of NEDD8Ala72Arg,
or whether attractive electrostatic interaction with the E1’s Gln
is required. A UBA3 Arg190Ala substitution would address
this question by removing barriers from the Arg side-chain,
without providing opportunities for favorable polar interactions
with the UBL Arg. GST-APPBP1-UBA3Arg190Ala binds
NEDD8Ala72Arg with a Kd value of 1.66 ( 0.01 µM. The
similar Kd values (1.02 ( 0.1 µM v 1.66 ( 0.01 µM) for the
Gln and Ala substitutions suggest that UBA3’s Arg190 prima-
rily acts as a gate that negatively selects against a UBL’s Arg72.
The UBA3 Arg190Ala substitution also allows binding to a
NEDD8 with a Lys substitution at residue 72, although in this
case a Gln does appear to impart more positive interactions (3-
fold better binding).
UBA3’s Residue 190 and NEDD8’s Residue 72 Do Not
Play EquiValent Roles in E1-Ubl SelectiVity. The UBA3
Arg190Ala-NEDD8Ala72Arg pair essentially swaps Arg and
Ala selectivity determinants between E1 and NEDD8. Thus,
we asked whether these E1 and UBL positions play
equivalent roles in determining binding with a complete set
of Ala, Arg, and Gln substitutions at both positions (Table
1, Figure 2). The results reveal consistent, nonequivalent,
directional effects. First, the wild-type E1-NEDD8 pair binds
best, ∼5-fold better than the “opposite” pair in which the
identities of UBA3’s residue 190 and NEDD8’s 72 have been
swapped [UBA3Arg190Ala and NEDD8Ala72Arg]. Second,
the “ubiquitinized” pair (with the UBA3Arg190Gln and
NEDD8Ala72Arg substitutions to residues found in ubiquitin’s
E1 and ubiquitin) associate with a ∼9-fold lower Kd than the
“opposite ubiquitinized” pair, wild-type UBA3 (Arg190) and
NEDD8Ala72Gln.
Interestingly, both the APPBP1-UBA3 Arg190Gln and
Arg190Ala variants preferentially bind to NEDD8Ala72Arg
(or NEDD8Ala72Lys), rather than to wild-type NEDD8
(Ala72), or the NEDD8Ala72Gln mutant. This raises the
possibility that an Arg serves a function beyond dictating
E1-UBL selectivity.
NEDD8’s E1 contains Additional Determinants Selecting
against Ubiquitin. Having established UBA3’s residue 190 as
gating against a UBL’s Arg72, we asked the extent to which
this single interaction establishes APPBP1-UBA3’s selectivity
against initial noncovalent binding to ubiquitin. Although
binding is too weak for us to measure a Kd within the limits of
our assay, some signal is detected for interactions between wild-
type GST-APPBP1-UBA3 and ubiquitinArg72Ala, but not for
wild-type ubiquitin (Figure 2D). In a related vein, GST-
APPBP1-UBA3 Arg190Gln and Arg190Ala do show evidence
of interaction with wild-type ubiquitin. Therefore, although the
same trends are observed for mutations allowing APPBP1-
UBA3 interaction with “ubiquitinized” NEDD8Ala72Arg, ad-
ditional residues also contribute to NEDD8 E1’s discrimination
against noncovalent binding to ubiquitin.
NEDD8’s E1-E2 Transthiolation with UBLs Harboring
Arg at Position 72. Although wild-type ubiquitin is excluded
from NEDD8’s E1, a previous study found that NEDD8’s
E1 could transfer the “NEDD8ylized” ubiquitinArg72Leu
mutant to NEDD8’s E2 (Ubc12), albeit with less efﬁciency
overall than the NEDD8 transthiolation cycle (22). This result
raised the question as to whether speciﬁcity was established
entirely by noncovalent binding by the E1, or whether the
ubiquitin mutation relieves discrimination against an Arg at
the UBL’s position 72 by APPBP1-UBA3 and Ubc12 during
transthiolation. To address this question, we assayed the
different APPBP1-UBA3 mutants for NEDD8Ala72Arg
transfer to Ubc12 (Figure 3). We observe no detectable
activity with wild-type APPBP1-UBA3, consistent with
gating against this “ubiquitinizing” mutation. However, both
the APPBP1-UBA3 Arg190Gln and Arg190Ala mutants can
transfer NEDD8Ala72Arg to Ubc12. Similar results are also
observed for ubiquitin, although reactions are less efﬁcient,
consistent with the weaker noncovalent binding of ubiquitin
to these mutants.
Crystallographic Dissection of Arg, Ala, and Gln at
UBA3’s Residue 190 and NEDD8’s Residue 72. Our bio-
chemical data pointed toward a directional gating mechanism
by which NEDD8’s E1’s Arg190 inﬂuences interaction with a
UBL’s residue 72. In order to understand the structural basis
underlying this speciﬁcity, we determined crystal structures of
three mutant APPBP1-UBA3-NEDD8 complexes: “wild-type-
opposite” [UBA3Arg190Ala-NEDD8Ala72Arg, 2.85 Å resolu-
tion]; “ubiquitinized” [UBA3Arg190Gln-NEDD8Ala72Arg,
3.05 Å resolution]; and “ubiquitinized-opposite” [UBA3Arg190
(wt)-NEDD8Ala72Gln, 2.90 Å resolution]. Details of data and
reﬁnement statistics are given in Table 2. Overall, for all three
complexes, the electron density 2Fo-Fc maps were continuous
and well-deﬁned over all four copies in the asymmetric units
(data not shown). Moreover, the side chains at both positions
NEDD8’s E1 residue 190 and NEDD8 residue 72 were clearly
present in simulated annealing omit maps (Figure 5), generated
Table 1: SPR-Measured Kd and RU Values for Interactions between
APPBP1-UBA3 Position 190 Variants and NEDD8 Position 72 Variants
interaction Kd (nM) Rmax (RU)
UBA3Arg190 (wt) + NEDD8Ala72 (wt) 333 ((1) 50.7 ((0.1)
UBA3Arg190 (wt) + NEDD8Ala72Arg >10000 n/a
UBA3Arg190 (wt) + NEDD8Ala72Gln 8750 ((70) 49.5 ((0.2)
UBA3Arg190 (wt) + NEDD8Ala72Lys >10000 n/a
UBA3Arg190Gln + NEDD8Ala72 (wt) 3460 ((10) 48.3 ((0.1)
UBA3Arg190Gln + NEDD8Ala72Arg 1020 ((10) 47.2 ((0.1)
UBA3Arg190Gln + NEDD8Ala72Gln >10000 n/a
UBA3Arg190Gln + NEDD8Ala72Lys 886 ((4) 47.3 ((0.1)
UBA3Arg190Ala + NEDD8Ala72 (wt) 5500 ((30) 43.9 ((0.1)
UBA3Arg190Ala + NEDD8Ala72Arg 1660 ((10) 43.1 ((0.1)
UBA3Arg190Ala + NEDD8Ala72Gln >10000 n/a
UBA3Arg190Ala + NEDD8Ala72Lys 2970 ((20) 54.3 ((0.1)
8964 Biochemistry, Vol. 47, No. 34, 2008 Souphron et al.from a model lacking the residues UBA3’s 190 and NEDD8’s
72. For each mutant complex, the four complexes in the
asymmetric unit are similar: “wild-type-opposite”, 0.5Å rmsd,
“ubiquitinized”, 0.6 Å rmsd, and “ubiquitinized-opposite”, 0.5
Å rmsd. Therefore, the ﬁgures display only one copy for each
mutant complex. The overall structures all superimpose well
with the prior wild-type APPBP1-UBA3-NEDD8 structure,
with rmsds between 0.4 and 0.5 Å.
Structures of “Wild-Type-Opposite” and “Ubiquitinized”
Complexes: Unlocking UBA3’s Gate against a UBL’s Arg72.
In order to understand how UBA3’s Arg190 gates against a
UBL’s Arg72, we compared the structures of the previously
determined wild-type APPBP1-UBA3-NEDD8 complex, in
which UBA3 harbors an Arg, and the “wild-type-opposite”
and “ubiquitinized” complexes, in which NEDD8 has an Arg.
Strikingly, in all three complexes, the Arg guanidium group
is in the same relative location (Figure 4). This explains how
UBA3’s Arg would gate against a UBL’s Arg72 by clashing
and repulsion. The results also show how simply removing
UBA3’s Arg190 side-chain with an Ala mutation allows a
UBL’s Arg.
In all three structures, the Arg makes many favorable
contacts (Figure 5). In the wild-type complex, Arg190 forms
hydrogen bonds with UBA3’s Tyr207 and Thr203, and a
FIGURE 2: Surface plasmon resonance analysis of APPBP1-UBA3 binding to UBLs. Representative sensorgrams (left) and binding curves
(right) from surface plasmon resonance interaction assays, performed as described in Experimental Procedures, for (A) GST-APPBP1-
UBA3Arg190 (wt), (B) GST-APPBP1-UBA3Arg190Gln, and (C) GST-APPBP1-UBA3Arg190Ala with NEDD8Ala72 (wt), NEDD8Ala72Arg,
NEDD8Ala72Gln, and NEDD8Ala72Lys, as indicated. (D) Representative sensorgrams (left) and binding curves (right) for ubiquitin binding
to GST-APPBP1-UBA3Arg190 (wt), GST-APPBP1-UBA3Arg190Gln, and GST-APPBP1-UBA3Arg190Ala, as indicated.
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static interactions are preserved when the Arg comes from
the mutant NEDD8. The aliphatic portion of the Arg side-
chain also preserves hydrophobic interactions with Tyr207
and Tyr321. In the “ubiquitinized” complex, a hydrogen bond
between NEDD8’s mutant Arg72 and UBA3’s mutant
Gln190 explains the moderate preference for the “ubiquiti-
nizing” Gln over an Ala at position 190 in UBA3.
Insights into Directionality of the UBA3 190 and UBL 72
gate from the “Wild-Type-Opposite” Structure. We wished
to obtain a structural understanding of the directional
preference toward residue identity at UBA3’s position 190
FIGURE 3: Altered E1 NEDD8 (APPBP1-UBA3)-E2 (Ubc12) transthiolation speciﬁcity for UBA3 Arg190 mutants. (A) Time-course of
forming the Ubc12-NEDD8 thioester complexes with 100 nM wild-type and indicated mutants of APPBP1-UBA3, 4 µM wild-type and
indicated mutants of NEDD8, and 3 µM Ubc12. Reactions were stopped at the indicated times, products were separated by SDS-PAGE
and detected by Western blotting with anti-NEDD8 antibodies. (B) Western blots of reactions performed as in panel A, except using the
indicated His-NEDD8 variants and His-ubiquitin, and probed with anti-His-tag antibodies.








beamline NSLS X25 ALS 8.2.2 ALS 8.2.2
space group P212121 P212121 P212121
cell dimensions
a, b, c (Å) 134.3, 198.5, 208.8 135.6, 198.1, 210.9 136.1, 198.9, 210.0
R,  , γ (°) 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0
resolution (Å) 3.05 2.85 2.90
Rmerge (%) 11.4 (56.6) 11.0 (39.3) 16.3 (46.8)
I/σI 12.3 (2.7) 14.4 (1.5) 13.2 (1.8)
completeness (%) 95.9 (97.2) 96.0 (81.9) 93.7 (78.6)
Reﬁnement
resolution (Å) 50.0-3.05 50.0-2.85 50.0-2.90
no. reﬂections 100137 127325 117851
Rwork/Rfree
a (%) 23.0/28.0 22.4/27.4 22.5/27.4
r.m.s deviations
bond lengths (Å) 0.009 0.008 0.008
bond angles (°) 1.59 1.51 1.44
Ramachandran Plot Statistics
most favored regions (%) 81.2 83.4 83.3
additional allowed regions (%) 18.6 16.4 16.5
generously allowed regions (%) 0.2 0.2 0.3
disallowed regions (%) 0.0 0.0 0.0
a Rwork ) Σ| Fobs - Fcalc |/Σ| Fobs|, where Fobs and Fcalc are the observed and calculated structure factors, respectively. Rfree ) Rwork calculated with
5% of the reﬂection data chosen randomly and omitted from the start of reﬁnement. Parentheses denote the last resolution shell.
8966 Biochemistry, Vol. 47, No. 34, 2008 Souphron et al.and NEDD8’s position 72, revealed from our binding assay.
Comparison of the wild-type (UBA3Arg190, NEDD8Ala72)
with the “wild-type-opposite” (UBA3 mutant Ala190, NEDD8
mutant Arg72) reveals that swapping the Arg side-chain
between UBA3 and NEDD8 removes van der Waals
contacts, between UBA3 Arg190s gamma and delta carbons
and Asp179’s beta carbon (Figure 5A-B). Asp179 is respon-
sible for orienting UBA3’s Arg151, which in turn aligns the
backbone of UBA3’s Mg2+-binding Asp146 and NEDD8’s
C-terminal Gly-Gly motif. Although at the resolution of our
structures subtle structural differences are not detectable, we
speculate that slight variations in this region inﬂuences
afﬁnity for NEDD8.
Although Arg-Gln and Gln-Arg electrostatic interactions
are observed in both the “ubiquitinized” (UBA3 mutant
Gln190, NEDD8 mutant Arg72) and “ubiquitinized-opposite”
(UBA3 Arg190, NEDD8 mutant Gln72) complexes, the
“ubiquitinized-opposite” (UBA3 Arg190, NEDD8 mutant
Gln72) interaction is lower afﬁnity. The Arg190 hydrophobic
contact to UBA3’s Asp179 is lost in both of these complexes,
as in the “wild-type-opposite” complex (Figure 5C-D).
Moreover, the UBA3 Asp179 - Arg salt-bridge is lost in the
“ubiquitinized-opposite”, in which the UBA3 Arg guanidium
group has moved away, in order to accommodate and form
a hydrogen bond with the NEDD8 mutant Gln side-chain
(Figure 4C).
The structure of the “ubiquitinized-opposite” complex
suggests that the relatively higher afﬁnity interaction between
wild-type UBA3, with an Arg190, and wild-type NEDD8,
with an Ala72 is an indirect effect. Despite the lack of
positive electrostatic 190-72 interactions, an Ala at NEDD8’s
position 72 allows proper positioning of UBA3’s Arg. By
contrast, in order to accommodate a Gln at NEDD8’s position
72, other interactions are disrupted for relocation of UBA3’s
Arg190 (Figure 4C, Figure 5D).
DISCUSSION
UBL modiﬁcations regulate a vast array of eukaryotic
pathways. Thus, it is of great interest to understand the
detailed mechanisms by which different UBLs are directed
to their targets, and thereby modify function. Ubiquitin’s and
NEDD8’s residue 72 has emerged as a key determinant
distinguishing protein-protein interactions between the two
cascades. Here we dissect the structural mechanisms by
which the identity of a UBL’s residue 72, and the corre-
sponding E1’s residue 190, dictates interaction selectivity.
We ﬁnd that ubiquitin’s Arg72 actively prevents misactiva-
tion by NEDD8’s E1 due to direct negative exclusion by
UBA3’s Arg190. This contrasts with a model where NEDD8’s
E1 simply lacks residues dictating positive interactions with
ubiquitin’s Arg72.
Negative selectivity has emerged as a general mechanism
separating the ubiquitin and NEDD8 pathways. In addition
to barriers preventing NEDD8’s E1 from interacting with
ubiquitin, NEDD8’s E2 (Ubc12) also displays negative
FIGURE 4: Structural basis for UBA3’s Arg190s negative selectivity against a UBL’s Arg72. Superimposition of wild-type (21) and mutant
APPBP1-UBA3-NEDD8 structures was performed using least-squares ﬁtting over all atoms in O (33). UBA3’s residue 190 is shown in
various shades of red; NEDD8’s residue 72 in yellow; nitrogen, blue; and oxygen, light red. (A) Overall superimposition of APPBP1-
UBA3Arg190Gln (rose)-NEDD8Ala72Arg (melon, “ubiquitinized”) and APPBP1-UBA3Arg190Ala (maroon)-NEDD8Ala72Arg (chartreuse,
“wild-type-opposite”) complexes, with close-up view around the NEDD8 mutant’s Arg72 and UBA3’s residue 190. (B) Close-up view
showing NEDD8 mutant Arg72 from APPBP1-UBA3Arg190Gln-NEDD8Ala72Arg (melon) and from APPBP1-UBA3Arg190Ala-
NEDD8Ala72Arg (chartreuse), and Arg190 (red) from wild-type APPBP1-UBA3-NEDD8. (C) Close-up view showing Arg190 (violet)
and NEDD8 mutant Gln72 from APPBP1-UBA3Arg190 (wt)-NEDD8Ala72Gln, and Arg190 (red) from wild-type APPBP1-UBA3-NEDD8.
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uitin (23). Ubc12’s UBL speciﬁcity, from NEDD8 to
ubiquitin, was switched 1010-fold simply by removing surface
elements, without substituting sequences of ubiquitin E2s
(23). NEDD8’s E1 also displays barriers against structures
conserved among ubiquitin E2s (36). It seems likely that
negative interactions will be found to play major roles in
distinguishing members of other UBL cascades. Indeed,
negative interactions may hinder binding between the HECT
E3 E6AP and the ubiquitin E2 UbcH5 (37), and the altered
speciﬁcity of a charge-swapped RING E3 CNOT4-UbcH5B
pair may involve altered negative selectivity as well as
designed positive interactions (38).
Subtle structural differences, which may be distributed
over ubiquitin’s and NEDD8’s entire surfaces, also contribute
substantial selectivity. Such differences appear to add E1-
UBL speciﬁcity, on top of the predominant role of a UBL’s
residue 72 (19, 22) (also Figure 2D, Figure 3B). Not
surprisingly, the native UBA3Arg190-NEDD8Ala72 interac-
tion is most favored. Our structural data suggest this may
be an indirect effect of proper positioning of UBA3’s
Arg190, rather than from direct positive interactions with
NEDD8’s Ala72. Fine variation also appears to contribute
at least a factor of 10 to the differential binding of NEDD8
and ubiquitinArg72Ala to the NEDD8-speciﬁc ubiquitin-like
protease DEN1/NEDP1/SENP8 (25, 26). Insights into how
slight differences in presentation of ubiquitin surface residues
can lead to large differences in afﬁnities come from the
ﬁnding that hydrophobic core mutations selectively diminish
binding to ubiquitin-interacting motifs, but not to ubiquitin-
associated domains (39).
In contrast to apparently indirect functions of NEDD8’s
residue 72, ubiquitin’s Arg72 mediates important positive
interactions with many cognate partners. The most striking
effect is observed for ubiquitin interactions with the ubiquitin
C-terminal hydrolase Yuh1, where the NEDD8Ala72Arg
mutant binds Yuh1 as well as ubiquitin (24). The structure
of a Yuh1-ubiquitin aldehyde complex revealed essential
positive interactions between Yuh1’s Asp35 and a UBL’s
Arg72 (24). In a related vein, a ubiquitin Arg72Ala mutation
decreases cleavage by the ubiquitin-speciﬁc protease HAUSP
(26). It seems that ubiquitin’s Arg72 likely makes positive
interactions with ubiquitin’s E1 (19, 20). Consistent with this
notion, we observe hydrogen bonding between a UBL’s
Arg72 and a “ubiquitinized” UBA3 Gln190 mutant. Ubiq-
uitin’s E1 also contains an Asp in place of UBA3’s Leu206
and Tyr207, which further contact NEDD8’s residue 72.
Thus, residue 72 in ubiquitin and NEDD8 appear to mediate
speciﬁcity in distinct ways.
It seems likely that structures mediating key positive
interactions in some other UBL pathways may also serve as
negative determinants that prevent interaction with noncog-
nate conjugation cascades. Indeed, it is possible that con-
ceptually related, but distinct mechanisms confer speciﬁcity
even among E1-UBL antecedents found in prokaryotes. The
bacterial enzymes MoeB and ThiF are prokaryotic ancestors
of E1s, with roles in molybdopterin and thiamin biosynthesis,
respectively (3, 40). MoeB and ThiF resemble the E1
adenylation domain both structurally and functionally,
catalyzing adenylation of the bacterial ubiquitin-fold proteins
MoaD and ThiS. Here, speciﬁcity may be dictated by UBL
insertions, between the  A and  B strands in MoaD and the
 D and  E strands in ThiS, which make unique contacts to
MoeB and ThiF, respectively (41, 42). Interestingly, the
insertions in both MoaD and ThiS contain arginines, which
may also gate against noncognate interactions.
FIGURE 5: Differential APPBP1-UBA3 interactions with NEDD8 for UBA3 residue 190 and NEDD8 residue 72 mutants. Stick-representation
close-up views, with UBA3 colored red and NEDD8 colored yellow, nitrogen blue, oxygen light-red, and hydrogen bonds shown as dashed
lines for (A) APPBP1-UBA3-NEDD8 (wild-type), (B) APPBP1-UBA3Arg190Ala-NEDD8Ala72Arg (“wild-type-opposite”), (C) APPBP1-
UBA3Arg190Gln-NEDD8Ala72Arg (“ubiquitinized”), and (D) APPBP1-UBA3Arg190 (wt)-NEDD8Ala72Gln (“ubiquitinized-opposite”)
complexes. Simulated annealing omit Fo-Fc electron density maps are shown in green mesh, contoured at 3σ over UBA3’s residue 190
and NEDD8’s residue 72 in panels B-D. The maps were calculated using the program CNS (32), after simulated annealing at 2000 K
omitting both UBA3’s residue 190 and NEDD8’s residue 72.
8968 Biochemistry, Vol. 47, No. 34, 2008 Souphron et al.Knowledge of the “code” for selective interactions will
lay a foundation for manipulating UBL ligation machineries
to transform protein activities as desired.
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